Want to join the conversation?
Based on preliminary analysis, $DHX's 3Q16 revenue will be $56MM, which is below its previous outlook of $57.5-58.5MM. Total adjusted EBITDA is expected to be below its previously guided range of $16-17MM at $14.8MM. Diluted EPS, excluding the impact of impairment of intangible assets and goodwill, will be $0.10, below its range of $0.11-0.12.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?